Keywords: مقاومت درمانی; Ibrutinib; Mathematical models; Clonal architecture; Venetoclax; CLL; Therapy resistance;
مقالات ISI مقاومت درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مقاومت درمانی; ASO; antisense oligonucleotides; BANCR; BRAF-activated non-coding RNA; CCAT1-L; colorectal cancer associated transcript 1-long isoform; cET; constrained EThyl; EMT; epithelial to mesenchymal transition; ERV; endogenous retroviral sequence; FDA; food and d
Keywords: مقاومت درمانی; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CatK; cathepsin K; CXCR4; C-X-C receptor type 4; DLL4; Delta-like ligand 4; GSC; glioma stem cell; EC; endothelial cell; ECM; extracellular matrix; GM-CSF; granulocyte/macrophage colony-stimu
Keywords: مقاومت درمانی; Metabolic reprogramming; Warburg metabolism; OXPHOS; Therapy resistance;
Keywords: مقاومت درمانی; ABC; ATP binding cassette; ADCC; antibody-dependent cell-mediated cytotoxicity; ALDH; aldehyde dehydrogenase; CBP; cAMP response element binding protein (CREB)-binding protein; CSC; cancer stem cell; CTC; circulating tumour cell; DAPT; N-[N-(3,5-difluorop
Keywords: مقاومت درمانی; Pancreatic cancer; GEMMs; Kinases; Cancer progression; Therapy resistance; Metabolism and desmoplasia;
Keywords: مقاومت درمانی; Cancer; Tumor-initiating cells (TICs); Cancer stem cells (CSCs); Therapy resistance; Metastasis; EMT; Relapse; Apoptosis; Signaling pathways; Lineage tracing
Keywords: مقاومت درمانی; Oral cancer; Cancer stem cells; Therapy resistance; Tumorigenicity;
Keywords: مقاومت درمانی; dormancy; dormancy-competent cancer stem cells; epigenetic/noncoding interactome; metastasis; therapy resistance
Keywords: مقاومت درمانی; metastasis; epithelial–mesenchymal plasticity; cancer stem cell; circulating tumor cell; therapy resistance
Keywords: مقاومت درمانی; EGFR; HER2; Breast cancer; ER; Cancer stem cells; Targeted therapy; Hormonal therapy; Therapy resistance;
Keywords: مقاومت درمانی; Cancer stem cells; HER2; ER; miRs; Targeted therapy; Hormonal therapy; Therapy resistance
Keywords: مقاومت درمانی; Melanoma; Therapy resistance; Tumour heterogeneity; Tumour plasticity
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells
Keywords: مقاومت درمانی; Epithelial ovarian cancer; Therapy resistance; NF-κB signaling pathway; Bay 11-7082;
A web platform for the network analysis of high-throughput data in melanoma and its use to investigate mechanisms of resistance to anti-PD1 immunotherapy
Keywords: مقاومت درمانی; MM; Malignant melanoma; HTD; high-throughput data; TF; Transcription factor; Systems biology; Immunotherapy; Therapy resistance; Melanoma; Network genomics; Databases;
Mini-reviewmicroRNAs as cancer therapeutics: A step closer to clinical application
Keywords: مقاومت درمانی; Metastases; Therapy resistance; Drug delivery; miR-34a; miR-15/16; miR-155;
PARP inhibitors: Clinical utility and possibilities of overcoming resistance
Keywords: مقاومت درمانی; PARP inhibitors; BRCA1/2 mutation; Therapy resistance; Ovarian cancer;
The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis
Keywords: مقاومت درمانی; Metastatic breast cancer; Non-metastatic breast cancer; Progression-free survival; Survival; Therapy resistance;
Clinical and biological effects of demethylating agents on solid tumours - A systematic review
Keywords: مقاومت درمانی; Epigenetics; Solid tumour; Demethylating agents; DNMT inhibitor; Therapy resistance; Immune response;
Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells
Keywords: مقاومت درمانی; Chemokines; Therapy resistance; CXCR2; Stem cell
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer
Keywords: مقاومت درمانی; GSK-3; Wnt/beta-catenin; PI3K; Akt; mTOR; Hedgehog; Notch; Targeted therapy; Therapy resistance;
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma
Keywords: مقاومت درمانی; Thyroid carcinoma; Tumorigenesis; Therapy resistance; PI3K; Akt; mTOR;
Role of ion channels in ionizing radiation-induced cell death
Keywords: مقاومت درمانی; Ion transport; Radiation; Cancer; Cell death; Therapy resistance; Ca2+-activated K+ channels
The Wnts of change: How Wnts regulate phenotype switching in melanoma
Keywords: مقاومت درمانی; Phenotype switching; Melanoma; Wnt signaling; Therapy resistance; Immune microenvironment
The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21
Keywords: مقاومت درمانی; Cancer progression; Cell cycle; Keep of function phenomenon; Therapy resistance
AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2+ breast tumor cells from Balb-neuT mice
Keywords: مقاومت درمانی; AKT; ErbB2; Estrogen receptor α; Therapy resistance; Breast cancer; Balb-neuT mice;
Targeting EMT in cancer: opportunities for pharmacological intervention
Keywords: مقاومت درمانی; Epithelial-mesenchymal transition (EMT); cancer; metastasis; invasion; therapy resistance; cancer stem cells; mesenchymal-epithelial transition (MET); therapeutic targets
Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption
Keywords: مقاومت درمانی; Synuclein gamma; Chaperone; HER2 signaling; Breast cancer; Therapy resistance; BCSG1; breast cancer specific gene 1; ERα; estrogen receptor α; Hsp; heat shock protein; mTOR; mammalian target of rapamycin; SNCA; synuclein α; SNCB; synuclein β; SNCG; sy
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
Keywords: مقاومت درمانی; DNA damage response; MicroRNAs; Cancer; Chemotherapy; Therapy resistance;
Lifetime prognosis of juvenile myoclonic epilepsy
Keywords: مقاومت درمانی; Juvenile myoclonic epilepsy; Prognosis; Remission; Therapy resistance; SUDEP; Subsyndromes; Long-term follow-up; Population-based studies; Epidemiology; Status epilepticus
Extracellular matrix components in breast cancer progression and metastasis
Keywords: مقاومت درمانی; Extracellular matrix; Metastatic niche; Mammary gland involution; Tissue remodeling; Metastatic breast cancer; Therapy resistance
Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats
Keywords: مقاومت درمانی; Epileptogenesis; Animal epilepsy model; Antiepileptic drugs; Therapy resistance; Kindling acquisition
Oncochannels
Keywords: مقاومت درمانی; Ion channels; Cancer; Neoplastic transformation; Malignant progression; Invasion and metastasis; Therapy resistance; Tumour suppressors
Stem cells in breast tumours: Are they ready for the clinic?
Keywords: مقاومت درمانی; Breast cancer; Stem cells; Therapy resistance; Cancer stem cells; Biomarkers;
MicroRNAs in ovarian cancer biology and therapy resistance
Keywords: مقاومت درمانی; EOC; epithelial ovarian cancer; OEC; ovarian endometrioid carcinoma; OSC; ovarian serous carcinoma; OCC; ovarian clear-cell carcinoma; HOSE; human ovarian surface epithelium cell line; Ovarian cancer; microRNA; miR-200 family; Let-7 family; Therapy resist
Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines
Keywords: مقاومت درمانی; breast cancer; inflammatory breast cancer; tumor heterogeneity; COX-2; metastasis; apoptosis; targeted therapy; therapy resistance
Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression
Keywords: مقاومت درمانی; rTMS; Brain stimulation; Major depression; Bipolar disorder; Therapy resistance
Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: Replication study in drug-free patients
Keywords: مقاومت درمانی; Repetitive transcranial magnetic stimulation; rTMS; Major depressive disorder; Response prediction; Therapy resistance